rs281865486
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_004614.5(TK2):c.133C>T(p.Gln45*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000136 in 1,613,338 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_004614.5 stop_gained
Scores
Clinical Significance
Conservation
Publications
- mitochondrial diseaseInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- mitochondrial DNA depletion syndrome, myopathic formInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae)
- autosomal recessive progressive external ophthalmoplegiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151950Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000398 AC: 1AN: 251360 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.0000137 AC: 20AN: 1461388Hom.: 0 Cov.: 30 AF XY: 0.00000963 AC XY: 7AN XY: 727006 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151950Hom.: 0 Cov.: 32 AF XY: 0.0000270 AC XY: 2AN XY: 74202 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25525159, 18508266, 29602790) -
This sequence change creates a premature translational stop signal (p.Gln45*) in the TK2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TK2 are known to be pathogenic (PMID: 20421844). This variant is present in population databases (rs281865486, gnomAD 0.002%). This premature translational stop signal has been observed in individual(s) with mitochondrial DNA depletion myopathy (PMID: 18508266). ClinVar contains an entry for this variant (Variation ID: 38974). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
Mitochondrial disease Pathogenic:1
TK2 p.Gln45Ter (c.133C>T) is a nonsense variant that introduces a premature stop codon at amino acid position 45, creating a truncated protein which is predicted to have a deleterious effect on TK2 gene function. It is also described as Gln87* and Q87X in the literature. This variant has been observed in a proband affected with mitochondrial disease in the compound heterozygous state (PMID:18508266). Functional studies have been reported; however, the significance of the findings remain unclear (PMID:28207748). This variant is not present at a significant frequency in gnomAD. In conclusion, we classify TK2 p.Gln45Ter (c.133C>T) as a pathogenic variant. -
Mitochondrial DNA depletion syndrome, myopathic form;C4310734:Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 3 Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at